| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 04/17/2013 | EP2581449A2 Novel genes related to glutaminyl cyclase |
| 04/17/2013 | EP2579858A2 Ivabradine-containing pharmaceutical composition |
| 04/17/2013 | CN103052627A Pyrimidine derivatives as fak inhibitors |
| 04/17/2013 | CN103044336A Acylthiourea compound, preparation method and application thereof |
| 04/17/2013 | CN103044335A Synthesis method of 3-benzyl-1-(3-methoxy benzyl)-2,4,5-trimethylimidazole chloride |
| 04/17/2013 | CN103044334A Refining method of ozagrel methyl ester |
| 04/17/2013 | CN103044333A Preparation method of high-purity sodium ozagrel |
| 04/17/2013 | CN103041606A Method for cleansing ionic liquid |
| 04/17/2013 | CN101456824B Alpha-amido-N-substituted amide compounds, medicament composition containing the same and use thereof |
| 04/17/2013 | CN101230041B Process and system of preparing ultra pure ionic liquids |
| 04/16/2013 | US8420688 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
| 04/16/2013 | US8420687 Pharmaceutical composition |
| 04/16/2013 | US8420684 Inhibitors of glutaminyl cyclase |
| 04/16/2013 | US8420683 5 substituted hydantoins |
| 04/16/2013 | US8420682 N-phenylacetamide derivatives, which inhibit the enzyme SOAT-1, and pharmaceutical and cosmetic compositions containing them |
| 04/16/2013 | US8420681 Dioxo-imidazolidine derivatives, which inhibit the enzyme SOAT-1, and pharmaceutical and cosmetic compositions containing them |
| 04/16/2013 | US8420680 NMDA receptor antagonists for neuroprotection |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/11/2013 | US20130090478 Novel compounds as opioid receptor modulators |
| 04/11/2013 | US20130090363 Ester compound and use thereof |
| 04/10/2013 | CN103038223A Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents |
| 04/10/2013 | CN103038220A Ester compound and use thereof |
| 04/10/2013 | CN103033583A Method for enriching and measuring ester components in natural perfume by using ionic liquid |
| 04/10/2013 | CN103030569A Preparation method of safflower pollen amino acids |
| 04/10/2013 | CN102285962B Phenoxy alkyl piperazine compounds, preparation method thereof and medicinal use thereof |
| 04/09/2013 | CA2704986C Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye |
| 04/09/2013 | CA2527192C Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 04/04/2013 | WO2013047758A1 Crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate, crystal of 5-hydroxy-1h-imidazole-4-carboxamide 3/4 hydrate, and method for producing same |
| 04/04/2013 | WO2013045431A1 Sulfonamide compounds and their use in the modulation retinoid - related orphan receptor |
| 04/04/2013 | WO2013011156A3 Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal |
| 04/04/2013 | WO2013011155A3 Method for preparation of medetomidine |
| 04/04/2013 | WO2012172120A3 2-(2,3-dimethylphenyl)-1-propanal and its use as perfume |
| 04/04/2013 | WO2012172119A3 Method for the preparation of medetomidine |
| 04/04/2013 | US20130085276 Carboxylation catalysts |
| 04/04/2013 | CA2850196A1 Crystal of 5-hydroxy-1h-imidazole-4-carboxamide-3/4 hydrate, method for producing the same and crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate |
| 04/03/2013 | EP2574607A1 PDE10 modulators |
| 04/03/2013 | CN103012276A Long-chain alkyl sulfoacid functionalized heteropolyacid salt, preparation method and application of long-chain alkyl sulfoacid functionalized heteropolyacid salt |
| 04/03/2013 | CN103012275A Method for producing high-purity N-alkyl imidazole |
| 04/03/2013 | CN103012274A Hydroxamic acid compound, and preparation method and use thereof |
| 04/03/2013 | CN103012273A Neutralized crystallization system and method of preparing caprolactam through caprolactam rearrangement solution |
| 04/03/2013 | CN103012272A Preparation method of imidazoline compound |
| 04/03/2013 | CN103012271A Imidazoline type corrosion inhibitor and preparation method of corrosion inhibition system |
| 04/03/2013 | CN102321029B Ornidazole compound and novel preparation method thereof |
| 04/03/2013 | CN102093296B Synthesis method of imidazoline compound |
| 04/03/2013 | CN101979394B A method to inhibit ethylene responses in plants |
| 04/03/2013 | CN101781157B Mono-iodo-substituted synthetic method for preparing aromatic or heteroaromatic compound |
| 04/02/2013 | US8410160 5-membered heterocycle-based P38 kinase inhibitors |
| 04/02/2013 | US8410155 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIA inhibitors |
| 04/02/2013 | US8410150 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 04/02/2013 | US8410141 Insecticidal arylpyrrolines |
| 04/02/2013 | CA2537292C 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 04/02/2013 | CA2496565C Non-nucleoside reverse transcriptase inhibitors |
| 03/28/2013 | WO2013042668A1 Radioactive fluorine labeled compound |
| 03/28/2013 | WO2013041402A1 Process for the purification of ionic liquids |
| 03/28/2013 | US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells" |
| 03/28/2013 | CA2849278A1 Radioactive fluorine-labeled compound |
| 03/27/2013 | EP2573068A1 Process for preparing intermediates of compounds useful as opioid receptor modulators |
| 03/27/2013 | EP2571909A1 Polymerizable ionic liquid comprising aromatic carboxylate anion |
| 03/27/2013 | EP2571908A1 Polymerizable ionic liquid compositions |
| 03/27/2013 | CN1972916B 肉桂酰胺类化合物 Cinnamic amides |
| 03/27/2013 | CN102993101A Imidazolium-based ionic liquids and application thereof |
| 03/27/2013 | CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/27/2013 | CN102989513A Acidic ionic liquid catalyst, synthesis method thereof, and method for catalyzing microcrystalline cellulose hydrolysis |
| 03/27/2013 | CN102417482B Method for synthesizing ozagrel ethyl ester or ozagrel methyl ester |
| 03/27/2013 | CN102344220B Method for treating metronidazole waste water |
| 03/27/2013 | CN102153555B Carbapenem compound containing amido formacyl heterocycle |
| 03/27/2013 | CN101448785B Novel dipeptidyl peptidase iv inhibitors and processes for preparation and pharmaceutical compositions thereof containing the same |
| 03/26/2013 | US8404732 Methods of treating ulcerative colitis |
| 03/26/2013 | US8404731 Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors |
| 03/26/2013 | US8404728 Small-molecule botulinum toxin inhibitors |
| 03/21/2013 | WO2013039567A1 Conversion of hf alkylation units for ionic liquid catalyzed alkylation processes |
| 03/21/2013 | WO2013039202A1 Novel acrylic acid derivative |
| 03/21/2013 | WO2013039187A1 Guanidinobenzoic acid compound |
| 03/21/2013 | WO2013037923A1 Method for synthesizing ionic liquids |
| 03/21/2013 | US20130072491 Prophylactic or therapeutic agent for diabetes or obesity |
| 03/21/2013 | US20130071439 Methods and compositions for treating biofilms |
| 03/21/2013 | CA2848561A1 Guanidinobenzoic acid compound |
| 03/21/2013 | CA2848169A1 Conversion of hf alkylation units for ionic liquid catalyzed alkylation processes |
| 03/20/2013 | EP2569276A1 Novel cationic lipids and methods of use thereof |
| 03/20/2013 | CN102985410A Combretastatin analogs for use in the treatment of cancer |
| 03/20/2013 | CN102985409A Method for preparing carbene in solution, novel stable form of carbene obtained in particular by means of said method, and uses thereof in catalysis |
| 03/20/2013 | CN102978253A Method for synthesising ezetimibe intermediate |
| 03/20/2013 | CN102977033A Synthesis method of alpha-halogenated alkenyl amide |
| 03/20/2013 | CN102977031A Method for synthesizing ionic liquid |
| 03/20/2013 | CN102977030A Novel trinuclear ionic liquid and preparation method thereof |
| 03/20/2013 | CN102060793B Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof |
| 03/19/2013 | US8399682 Substituted (pyrazolylcarbonyl)imidazolidinones and their use |
| 03/19/2013 | US8399501 Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof |
| 03/19/2013 | US8399500 Method of synthesizing ergothioneine and analogs |
| 03/19/2013 | US8399499 3- to 7-membered 1,3-diaza-4-OXO-heterocyclic derivatives capable of releasing active aldehydes or ketones |
| 03/19/2013 | US8399463 Imidazole derivatives |
| 03/19/2013 | CA2319465C Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 03/14/2013 | WO2013036869A2 Compositions, methods, and systems for the synthesis and use of imaging agents |
| 03/14/2013 | WO2013036766A1 Small molecule naphthoquinone- and phthalimide-based lipocations as anti-parasitic agents |
| 03/14/2013 | WO2013034506A1 Pde10 modulators |
| 03/14/2013 | WO2012166778A3 Conjugates of nitroimidazoles and their use as chemotherapeutic agents |
| 03/14/2013 | US20130066081 Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof |
| 03/14/2013 | US20130065861 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 03/14/2013 | CA2848147A1 Compositions, methods, and systems for the synthesis and use of imaging agents |
| 03/14/2013 | CA2844652A1 Pde10 modulators |